2009
DOI: 10.2471/blt.09.064147
|View full text |Cite
|
Sign up to set email alerts
|

Global disparities in the epilepsy treatment gap: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

11
327
0
12

Year Published

2009
2009
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 363 publications
(351 citation statements)
references
References 44 publications
11
327
0
12
Order By: Relevance
“…About three fourths of people with epilepsy living in low-and middle-income countries do not get the treatment they need because antiepileptic drugs are inaccessible or too expensive. 1, 3,4 Nevertheless, not all patients respond to available medical treatments, with increasing evidence that surgery and other treatments (e.g. neurostimulation and diet) can be beneficial.…”
Section: Introductionmentioning
confidence: 99%
“…About three fourths of people with epilepsy living in low-and middle-income countries do not get the treatment they need because antiepileptic drugs are inaccessible or too expensive. 1, 3,4 Nevertheless, not all patients respond to available medical treatments, with increasing evidence that surgery and other treatments (e.g. neurostimulation and diet) can be beneficial.…”
Section: Introductionmentioning
confidence: 99%
“…This 90% treatment gap was corroborated by studies from northern and southern Tanzania showing that 76% and 95% of people with epilepsy, respectively, had not been treated [12,19]. Dramatic global disparities in this treatment gap were identified by a systematic review which showed that 75% and fewer than 10% of PWE from low-income and high-income countries, respectively, were untreated or insufficiently treated for their epilepsy [36]. A recent study from Kenya demonstrated an epilepsy treatment gap of 62% using serum antiepileptic drug levels as a measure of compliance and found that self-reporting of compliance to antiepileptic medication was very unreliable when compared to the serum antiepileptic drug levels [37,38].…”
Section: Treatment Gap Of Epilepsy In Sub-saharan Africamentioning
confidence: 66%
“…In stark contrast, many high‐income countries have a treatment gap of less than 10% 1. This disparity is especially unfortunate in view of the fact that epilepsy treatment is inexpensive.…”
Section: Health and Economic Burden Of Epilepsymentioning
confidence: 99%